Kepler ups Redcare Pharmacy on leadership in Germany's e-prescription market

Redcare Pharmacy NV

14/03/2025 09:59

** Kepler Cheuvreux upgrades Germany's Redcare Pharmacy RDC.DE to "buy" from "hold", saying the online drug retailer has confirmed its leadership in the country's e-prescription market with "exceptional" Q4 results

** With a 142% surge in German prescription drug sales in Q4 and accelerating customer acquisition, Kepler says the e-prescription business is fully de-risked and well positioned for sustained growth

** "We see continued revenue growth, margin expansion, and automation benefits supporting long-term value creation," it adds

** A recent ruling by the European Court of Justice allowing discounts on prescription medicines provides a competitive advantage, though potential regulatory risks persist, it adds

** Out of 15 analysts that cover Redcare Pharmacy, ten rate it "strong buy" or "buy", ​three "hold" and two​ "strong sell" or "sell" - LSEG

 (Reporting by Tiago Brandao)

 ((Tiago.Brandao@thomsonreuters.com;))